Is Jiangxi Rimag Group Co., Ltd. (HKG:2522) Trading At A 47% Discount?
Aug 15
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Healthcare Services Industry Analysis
UpdatedAug 16, 2025
DataAggregated Company Financials
Companies56
- 7D3.6%
- 3M3.8%
- 1Y-6.3%
- YTD-5.0%
Over the last 7 days, the Healthcare Services industry has risen 3.6%, driven by gains from Sinopharm Group of 3.7%. In the past year, the industry is down 6.3%. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 17 Aug 2025 | HK$235.4b | HK$823.8b | HK$13.0b | 13.9x | 18.2x | 0.3x |
| Tue, 15 Jul 2025 | HK$218.9b | HK$827.8b | HK$13.1b | 13x | 16.8x | 0.3x |
| Thu, 12 Jun 2025 | HK$242.9b | HK$809.4b | HK$10.8b | 14x | 22.5x | 0.3x |
| Sat, 10 May 2025 | HK$211.5b | HK$796.7b | HK$10.4b | 11.4x | 20.3x | 0.3x |
| Mon, 07 Apr 2025 | HK$216.8b | HK$798.3b | HK$10.4b | 12.8x | 20.8x | 0.3x |
| Wed, 05 Mar 2025 | HK$203.1b | HK$807.7b | HK$14.5b | 12.5x | 14x | 0.3x |
| Fri, 31 Jan 2025 | HK$199.3b | HK$812.0b | HK$14.6b | 12.6x | 13.6x | 0.2x |
| Sun, 29 Dec 2024 | HK$225.4b | HK$803.4b | HK$14.5b | 11.9x | 15.6x | 0.3x |
| Tue, 26 Nov 2024 | HK$218.0b | HK$811.4b | HK$14.6b | 12.7x | 14.9x | 0.3x |
| Thu, 24 Oct 2024 | HK$222.2b | HK$823.5b | HK$15.2b | 13.2x | 14.6x | 0.3x |
| Sat, 21 Sep 2024 | HK$197.1b | HK$842.1b | HK$15.7b | 13.5x | 12.6x | 0.2x |
| Mon, 19 Aug 2024 | HK$226.2b | HK$828.4b | HK$12.7b | 10.6x | 17.9x | 0.3x |
| Wed, 17 Jul 2024 | HK$236.9b | HK$818.1b | HK$12.5b | 10.8x | 19x | 0.3x |
| Fri, 14 Jun 2024 | HK$259.5b | HK$821.8b | HK$12.6b | 12.2x | 20.7x | 0.3x |
| Sun, 12 May 2024 | HK$261.5b | HK$824.1b | HK$12.6b | 12.3x | 20.8x | 0.3x |
| Tue, 09 Apr 2024 | HK$223.4b | HK$821.9b | HK$12.7b | 11.6x | 17.6x | 0.3x |
| Thu, 07 Mar 2024 | HK$241.2b | HK$814.2b | HK$11.8b | 13.3x | 20.5x | 0.3x |
| Sat, 03 Feb 2024 | HK$221.9b | HK$825.6b | HK$12.1b | 14.1x | 18.3x | 0.3x |
| Mon, 01 Jan 2024 | HK$245.8b | HK$824.2b | HK$12.5b | 15.3x | 19.6x | 0.3x |
| Wed, 29 Nov 2023 | HK$262.5b | HK$816.8b | HK$12.3b | 15.5x | 21.3x | 0.3x |
| Fri, 27 Oct 2023 | HK$262.3b | HK$800.9b | HK$12.3b | 13.3x | 21.4x | 0.3x |
| Sun, 24 Sep 2023 | HK$286.9b | HK$803.6b | HK$12.7b | 12.7x | 22.6x | 0.4x |
| Tue, 22 Aug 2023 | HK$289.5b | HK$777.4b | HK$9.9b | 11.4x | 29.3x | 0.4x |
| Thu, 20 Jul 2023 | HK$327.9b | HK$801.6b | -HK$180,004,263.00 | 11.7x | -1821.7x | 0.4x |
| Sat, 17 Jun 2023 | HK$315.7b | HK$775.6b | HK$690.6m | 13.5x | 457.1x | 0.4x |
| Mon, 15 May 2023 | HK$326.1b | HK$793.7b | HK$1.1b | 12x | 286.4x | 0.4x |
| Wed, 12 Apr 2023 | HK$339.0b | HK$799.8b | HK$1.9b | 11.3x | 178.3x | 0.4x |
| Fri, 10 Mar 2023 | HK$319.9b | HK$775.9b | HK$3.4b | 15.9x | 94.6x | 0.4x |
| Sun, 05 Feb 2023 | HK$318.5b | HK$796.3b | HK$3.5b | 16.4x | 90x | 0.4x |
| Tue, 03 Jan 2023 | HK$296.9b | HK$778.5b | HK$3.2b | 14.3x | 93.3x | 0.4x |
| Thu, 01 Dec 2022 | HK$270.9b | HK$751.8b | HK$2.6b | 12.9x | 103.8x | 0.4x |
| Sat, 29 Oct 2022 | HK$188.3b | HK$671.8b | -HK$2,214,669,786.00 | 13.5x | -85x | 0.3x |
| Mon, 26 Sep 2022 | HK$199.3b | HK$666.3b | -HK$2,690,470,352.00 | 14.5x | -74.1x | 0.3x |
| Wed, 24 Aug 2022 | HK$216.1b | HK$683.2b | -HK$1,503,048,872.00 | 16.8x | -143.8x | 0.3x |
Price to Earnings Ratio
-143.8x
Current Industry PE
- Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 18.2x which is higher than its 3-year average PE of -37.7x.
- The industry is trading close to its 3-year average PS ratio of 0.32x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 6.3% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 2.10% | |
| Healthcare | 6.53% | |
| Healthcare Services | 3.63% | |
| Healthcare Distributors | 4.10% | |
| Healthcare Services | 4.03% | |
| Healthcare Facilities | 1.52% | |
| Managed Healthcare | 0% | 0 |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 27.1%, which is higher than its past year's earnings decline of 17.4% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading close to its 3-year average of 11.8x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 27% over the next 5 years.
- This is better than its past earnings decline of 17% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 8.7% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1099 Sinopharm Group | HK$19.57 | 3.7% +HK$2.2b | -1.2% | PE7.9x | |
| 2522 Jiangxi Rimag Group | HK$19.89 | 29.5% +HK$1.7b | 7.2% | PS8.8x | |
| 1931 IVD Medical Holding | HK$8.72 | 11.2% +HK$1.4b | 1,262.5% | PE49.8x | |
| 874 Guangzhou Baiyunshan Pharmaceutical Holdings | HK$18.30 | 2.7% +HK$780.4m | -7.6% | PE10.1x | |
| 9885 YSB | HK$10.10 | 9.0% +HK$563.6m | 27.5% | PE209.7x |
